Epacadostat, Idarubicin and Cytarabine (EIC) in AML
Clinical trial NCT03444649 · WITHDRAWN
Trial details
- NCT number
- NCT03444649
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2019-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.